Study of TL117 in Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma
Status:
Not yet recruiting
Trial end date:
2024-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the safety, pharmacokinetic and efficacy of TL117 plus
paclitaxel in patients with recurrent or metastatic head and neck cancer.